Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function
MG53 is a muscle-specific TRIM-family protein that presides over the cell membrane repair response. Here, we show that MG53 present in blood circulation acts as a myokine to facilitate tissue injury-repair and regeneration. Transgenic mice with sustained elevation of MG53 in the bloodstream (tPA-MG53) have a healthier and longer life-span when compared with littermate wild type mice. The tPA-MG53 mice show normal glucose handling and insulin signaling in skeletal muscle, and sustained elevation of MG53 in the bloodstream does not have a deleterious impact on db/db mice. More importantly, the tPA-MG53 mice display remarkable dermal wound healing capacity, enhanced muscle performance, and improved injury-repair and regeneration. Recombinant human MG53 protein protects against eccentric contraction-induced acute and chronic muscle injury in mice. Our findings highlight the myokine function of MG53 in tissue protection and present MG53 as an attractive biological reagent for regenerative medicine without interference with glucose handling in the body.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Nature communications - 10(2019), 1 vom: 11. Okt., Seite 4659 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bian, Zehua [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Calcium |
|---|
| Anmerkungen: |
Date Completed 04.02.2020 Date Revised 10.01.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-019-12483-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM302117350 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM302117350 | ||
| 003 | DE-627 | ||
| 005 | 20231225110038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-019-12483-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1007.xml |
| 035 | |a (DE-627)NLM302117350 | ||
| 035 | |a (NLM)31604915 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bian, Zehua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.02.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a MG53 is a muscle-specific TRIM-family protein that presides over the cell membrane repair response. Here, we show that MG53 present in blood circulation acts as a myokine to facilitate tissue injury-repair and regeneration. Transgenic mice with sustained elevation of MG53 in the bloodstream (tPA-MG53) have a healthier and longer life-span when compared with littermate wild type mice. The tPA-MG53 mice show normal glucose handling and insulin signaling in skeletal muscle, and sustained elevation of MG53 in the bloodstream does not have a deleterious impact on db/db mice. More importantly, the tPA-MG53 mice display remarkable dermal wound healing capacity, enhanced muscle performance, and improved injury-repair and regeneration. Recombinant human MG53 protein protects against eccentric contraction-induced acute and chronic muscle injury in mice. Our findings highlight the myokine function of MG53 in tissue protection and present MG53 as an attractive biological reagent for regenerative medicine without interference with glucose handling in the body | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 7 | |a Insulin |2 NLM | |
| 650 | 7 | |a MG53 protein, mouse |2 NLM | |
| 650 | 7 | |a Membrane Proteins |2 NLM | |
| 650 | 7 | |a Glucose |2 NLM | |
| 650 | 7 | |a IY9XDZ35W2 |2 NLM | |
| 650 | 7 | |a Calcium |2 NLM | |
| 650 | 7 | |a SY7Q814VUP |2 NLM | |
| 700 | 1 | |a Wang, Qiang |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Xinyu |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Ki Ho |e verfasserin |4 aut | |
| 700 | 1 | |a Kramer, H Fritz |e verfasserin |4 aut | |
| 700 | 1 | |a McDougal, Alan |e verfasserin |4 aut | |
| 700 | 1 | |a Laping, Nicholas J |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Sanjay |e verfasserin |4 aut | |
| 700 | 1 | |a Adesanya, T M Ayodele |e verfasserin |4 aut | |
| 700 | 1 | |a Sermersheim, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Yi, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xinxin |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Junwei |e verfasserin |4 aut | |
| 700 | 1 | |a Gumpper, Kristyn |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Qiwei |e verfasserin |4 aut | |
| 700 | 1 | |a He, Duofen |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Pei-Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Haichang |e verfasserin |4 aut | |
| 700 | 1 | |a Guan, Fangxia |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Jingsong |e verfasserin |4 aut | |
| 700 | 1 | |a Kohr, Mark J |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, Chunyu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Hua |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Jianjie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 10(2019), 1 vom: 11. Okt., Seite 4659 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2019 |g number:1 |g day:11 |g month:10 |g pages:4659 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-019-12483-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2019 |e 1 |b 11 |c 10 |h 4659 | ||